Does ChAdOx1-S and BNT162b2 heterologous prime-boost vaccination trigger higher rates of vaccine-related adverse events?

BACKGROUND: There has been significant international interest in heterologous prime-boost COVID-19 vaccination. However, it is linked with different intensity and frequency of adverse events. This study aimed to assess the safety of ChAdOx1-S and BNT162b2 vaccines when given as heterologous prime-bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Haji, Alhan, Alkattan, Abdallah, Mahmoud, Nagla, Elkagam, Elfadil, Hassanein, Mustafa, Alfaifi, Amal, Al-Tawfiq, Jaffar A., Alabdulkareem, Khaled, Jokhdar, Hani, Radwan, Nashwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Coronavirus (COVID-19) Collection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005969/
https://www.ncbi.nlm.nih.gov/pubmed/37025346
http://dx.doi.org/10.1016/j.ijregi.2023.03.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005969/
https://www.ncbi.nlm.nih.gov/pubmed/37025346
http://dx.doi.org/10.1016/j.ijregi.2023.03.003

Ejemplares similares